Hot Investor Mandate: Global Pharmaceutical Company Seeks to Partner with Therapeutics Assets & Digital Health Solutions with Focus on Respiratory Disease, Rare Disease, and Cardiovascular Care

22 Aug

A global pharmaceutical company with an established USA-based subsidiary, is interested in forming partnerships with emerging life science and digital health companies that are relevant to the company’s  pharmaceutical pipeline. These partnerships may include in-licensing, global or regional rights, and potentially also equity investments in venture financing rounds. The firm will consider partnerships with emerging companies based anywhere in the world.

The firm is interested in therapeutic assets, with a focus on the respiratory space, and also rare diseases, and cardiovascular care in a hospital setting. In North America, the firm focuses on drugs at Phase II through commercial stages; however the firm will consider opportunities at any stage from academic work onwards.  The firm is also interested in digital health solutions related to its therapeutic business, such as digital products that help with patient adherence or compliance, or which use data in ways that can help the firm understand or identify patient populations in its core areas (particularly rare diseases).

The firm does not have specific company or management team requirements.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: